Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001697751-17-000001
Filing Date
2017-02-09
Accepted
2017-02-09 16:18:21
Documents
1
Effectiveness Date
2017-02-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6571
  Complete submission text file 0001697751-17-000001.txt   7592
Mailing Address 810 WYMAN PARK DRIVE BALTIMORE MD 21211
Business Address 810 WYMAN PARK DRIVE BALTIMORE MD 21211 410-657-2627
AsclepiX Therapeutics, LLC (Filer) CIK: 0001697751 (see all company filings)

EIN.: 452149440 | State of Incorp.: MD | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-280429 | Film No.: 17587787